Global availability of biologic medications for treatment of moderate to severe atopic dermatitis
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Authors
- Valéria Aoki (ORCID: https://orcid.org/0000-0003-4256-4413)
- Carsten Flohr (ORCID: https://orcid.org/0000-0003-4884-6286)
- Alain Taı̈eb (ORCID: https://orcid.org/0000-0002-0928-8608)
- Claire Quigley (ORCID: https://orcid.org/0000-0002-9687-6351)
- Alan D. Irvine (ORCID: https://orcid.org/0000-0002-9048-2044)
- Sandipan Dhar (ORCID: https://orcid.org/0000-0002-9304-2212)
- Esther E. Freeman (ORCID: https://orcid.org/0000-0001-7751-9466)
- Elisha Myers (ORCID: https://orcid.org/0000-0002-9749-8671)
- Noel D. McCarthy
- NCoza Dlova
Institutions
- Harvard University (US)
- Université de Bordeaux (FR)
- Inserm (FR)
- Universidade de São Paulo (BR)
- King's College London (GB)
- Trinity College Dublin (IE)
- Massachusetts General Hospital (US)
- Bordeaux Population Health (FR)
- Institute of Neurosciences Kolkata (IN)
- Institute of Child Health (IN)
- Hospital Universitário da Universidade de São Paulo (BR)
- Florida Atlantic University (US)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2026-09-17
- DOI
- https://doi.org/10.1111/jdv.70699
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00